Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

NCT03807999 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasm

Interventions

DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

Hacettepe University

Collaborators

[object Object]